International Patent for Domestic Covid-19 Medicine

A knowledge-based company has recently received an international patent certificate for a medicine that reduces the side-effects of Covid-19.
With the efforts of 40 Iranian researchers from eminent domestic universities, Saliravira was unveiled in the third month of the previous Iranian year (May 22-June 21, 2021), for which it received a domestic patent certificate,” Reza Ramezani, the CEO of Mim Daroo Company, was quoted as saying by the Vice Presidency for Science and Technology.
“The code of ethics and clinical trial license were obtained from the Iran University of Medical Sciences, which is a branch of the World Intellectual Property Organization in Iran, and then pre-clinical and clinical trials were conducted,” he added.
Ramezani said the company signed a contract with a reputable firm in Europe to assist in completing the technical aspects of international patenting, in which Iran does not have much experience.